Case Reports
doi: 10.1111/j.1365-2133.1994.tb02906.x.
Juvenile dermatomyositis: treatment with intravenous gammaglobulin
Affiliations
- PMID: 7510124
- DOI: 10.1111/j.1365-2133.1994.tb02906.x
Item in Clipboard
Case Reports
Juvenile dermatomyositis: treatment with intravenous gammaglobulin
Br J Dermatol.
1994 Feb.
Abstract
High-dose intravenous gammaglobulin (IVGG) has proved to be effective in the treatment of a number of immune disorders. We report two patients with juvenile dermatomyositis (DM) who improved with IVGG therapy. These patients had become refractory to corticosteroids and had developed unacceptable steroid toxicity. We suggest that IVGG can be useful in the treatment of juvenile DM, by reducing steroid requirements, and replacing immunosuppressive drugs.
Similar articles
-
Treatment of dermatomyositis with intravenous gammaglobulin.Am J Med. 1991 Aug;91(2):169-72. doi: 10.1016/0002-9343(91)90010-u. Am J Med. 1991. PMID: 1714236
-
Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.Am J Med. 1991 Aug;91(2):162-8. doi: 10.1016/0002-9343(91)90009-m. Am J Med. 1991. PMID: 1714235
-
[Dramatic effects of high-dose intravenous gammaglobulin in each patient with intractable dermatomyositis and polymyositis].No To Hattatsu. 1989 Nov;21(6):523-8. No To Hattatsu. 1989. PMID: 2478176 Japanese.
-
[Experimental treatment with high-dose gamma globulins in autoimmune diseases].Pediatr Med Chir. 1993 Jul-Aug;15(4):337-40. Pediatr Med Chir. 1993. PMID: 7505433 Review. Italian.
-
Intravenous gamma-globulin therapy in systemic lupus erythematosus and immune complex disease.Clin Immunol Immunopathol. 1989 Nov;53(2 Pt 2):S164-9. doi: 10.1016/0090-1229(89)90082-2. Clin Immunol Immunopathol. 1989. PMID: 2477186 Review.
Cited by
-
Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.Paediatr Drugs. 2010;12(1):23-34. doi: 10.2165/10899380-000000000-00000. Paediatr Drugs. 2010. PMID: 20034339 Review.
-
Use of Rescue Therapy with IVIG or Cyclophosphamide in Juvenile Myositis.Curr Rheumatol Rep. 2021 Mar 8;23(4):24. doi: 10.1007/s11926-021-00990-3. Curr Rheumatol Rep. 2021. PMID: 33686540 Review.
-
Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases.Rheumatol Int. 2005 Apr;25(3):211-4. doi: 10.1007/s00296-003-0422-0. Epub 2004 Jan 14. Rheumatol Int. 2005. PMID: 14722731
-
Efficacy of intravenous immunoglobulin therapy in a case of juvenile dermatomyositis.Clin Rheumatol. 1996 Mar;15(2):215-6. doi: 10.1007/BF02230347. Clin Rheumatol. 1996. PMID: 8777863 No abstract available.
-
Juvenile dermatomyositis: recognition and treatment.Paediatr Drugs. 2002;4(5):315-21. doi: 10.2165/00128072-200204050-00004. Paediatr Drugs. 2002. PMID: 11994036 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
